Published in J Geriatr Cardiol on May 01, 2015
Nanoparticle-Based and Bioengineered Probes and Sensors to Detect Physiological and Pathological Biomarkers in Neural Cells. Front Neurosci (2015) 0.81
Integrins and integrin-related proteins in cardiac fibrosis. J Mol Cell Cardiol (2015) 0.80
Lower mean corpuscular hemoglobin concentration is associated with poorer outcomes in intensive care unit admitted patients with acute myocardial infarction. Ann Transl Med (2016) 0.79
Effect of the Diagnosis of Inflammatory Bowel Disease on Risk-Adjusted Mortality in Hospitalized Patients with Acute Myocardial Infarction, Congestive Heart Failure and Pneumonia. PLoS One (2016) 0.77
Risk of acute myocardial infarction in patients with gastroesophageal reflux disease: A nationwide population-based study. PLoS One (2017) 0.75
Chemokines and Heart Disease: A Network Connecting Cardiovascular Biology to Immune and Autonomic Nervous Systems. Mediators Inflamm (2016) 0.75
Network Analysis-Based Approach for Exploring the Potential Diagnostic Biomarkers of Acute Myocardial Infarction. Front Physiol (2016) 0.75
The importance of depression and alcohol use in coronary artery bypass graft surgery patients: risk factors for delirium and poorer quality of life. J Geriatr Cardiol (2016) 0.75
MDCO-216 Does Not Induce Adverse Immunostimulation, in Contrast to Its Predecessor ETC-216. Cardiovasc Drugs Ther (2017) 0.75
PRDX2 in Myocyte Hypertrophy and Survival is Mediated by TLR4 in Acute Infarcted Myocardium. Sci Rep (2017) 0.75
Leukocyte diversity in resolving and nonresolving mechanisms of cardiac remodeling. FASEB J (2017) 0.75
Profiling the Evolution of Inflammatory Response and Exploring Its Prognostic Significance in Acute Myocardial Infarction: The First Step to Establishing Anti-Inflammatory Strategy. Acta Cardiol Sin (2017) 0.75
IL-1β Inhibition in Cardiovascular Complications Associated to Diabetes Mellitus. Front Pharmacol (2017) 0.75
The inflammatory response in myocardial infarction. Cardiovasc Res (2002) 7.92
Myocardial infarction accelerates atherosclerosis. Nature (2012) 4.48
Cardiovascular effects of tumour necrosis factor α antagonism in patients with acute myocardial infarction: a first in human study. Heart (2013) 3.94
The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury. Cardiovasc Res (2013) 3.92
Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation (2000) 3.66
Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Circulation (2004) 3.38
Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction:a possible role for left ventricular remodeling. J Am Coll Cardiol (2002) 3.27
Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation (1998) 3.19
A clinical perspective of IL-1β as the gatekeeper of inflammation. Eur J Immunol (2011) 3.14
Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury. Circulation (2011) 2.94
Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes. Eur Heart J (2006) 2.93
Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis. J Exp Med (2012) 2.92
Increased platelet binding to circulating monocytes in acute coronary syndromes. Circulation (2002) 2.89
Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction. Circ Res (2007) 2.69
Microparticles in cardiovascular diseases. Cardiovasc Res (2003) 2.62
Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation (2000) 2.56
The Th17/Treg imbalance in patients with acute coronary syndrome. Clin Immunol (2008) 2.48
Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction. Am J Cardiol (2008) 2.26
NLRP3 inflammasome as a novel player in myocardial infarction. Int Heart J (2014) 2.22
Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res (2007) 2.22
Macrophage roles following myocardial infarction. Int J Cardiol (2008) 2.14
Unusual CD4+CD28null T lymphocytes and recurrence of acute coronary events. J Am Coll Cardiol (2007) 2.09
Temporal dynamics of cardiac immune cell accumulation following acute myocardial infarction. J Mol Cell Cardiol (2013) 2.02
Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and incident coronary heart disease: the PRIME Study. Atherosclerosis (2003) 2.02
Significance of total and differential leucocyte count in patients with acute myocardial infarction treated with primary coronary angioplasty. Eur Heart J (2006) 1.99
Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events. Circulation (1999) 1.94
CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography. J Am Coll Cardiol (2012) 1.92
The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse. Proc Natl Acad Sci U S A (2011) 1.81
Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. J Am Coll Cardiol (2001) 1.74
Elevated peripheral blood mononuclear cell count is an independent predictor of left ventricular remodeling in patients with acute myocardial infarction. J Cardiol (2010) 1.59
B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction. Nat Med (2013) 1.43
Neutrophils and clinical outcomes in patients with acute coronary syndromes and/or cardiac revascularisation. A systematic review on more than 34,000 subjects. Thromb Haemost (2011) 1.40
Direct contact between T lymphocytes and monocytes is a major pathway for induction of metalloproteinase expression. J Biol Chem (1994) 1.36
Circulating CD4+CD25hiCD127lo regulatory T-Cell levels do not reflect the extent or severity of carotid and coronary atherosclerosis. Arterioscler Thromb Vasc Biol (2010) 1.33
Toll-like receptor 4 deficiency: smaller infarcts, but no gain in function. BMC Physiol (2007) 1.19
Novel role of platelets in mediating inflammatory responses and ventricular rupture or remodeling following myocardial infarction. Arterioscler Thromb Vasc Biol (2011) 1.15
Macrophage migration inhibitory factor as a redox-sensitive cytokine in cardiac myocytes. Cardiovasc Res (2001) 1.13
Aging might increase myocardial ischemia / reperfusion-induced apoptosis in humans and rats. Age (Dordr) (2011) 1.13
The CD14++CD16+ monocyte subset and monocyte-platelet interactions in patients with ST-elevation myocardial infarction. J Thromb Haemost (2012) 1.11
Decrease in circulating myeloid dendritic cell precursors in coronary artery disease. J Am Coll Cardiol (2006) 1.09
The immune system and the remodeling infarcted heart: cell biological insights and therapeutic opportunities. J Cardiovasc Pharmacol (2014) 1.08
CRP and the risk of atherosclerotic events. Semin Immunopathol (2009) 1.06
TH1/TH2 functional imbalance after acute myocardial infarction: coronary arterial inflammation or myocardial inflammation. J Clin Immunol (2005) 1.04
Toll-like receptors and myocardial inflammation. Int J Inflam (2011) 1.03
Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and their association with clinical outcome, troponin T and C-reactive protein in patients with acute coronary syndromes. Clin Biochem (2007) 1.00
Number of microparticles generated during acute myocardial infarction and stable angina correlates with platelet activation. Arch Med Res (2012) 0.99
T-helper 2 immunity is associated with reduced risk of myocardial infarction and stroke. Arterioscler Thromb Vasc Biol (2013) 0.98
C-reactive Protein as a Predictor of Adverse outcome in Patients with Acute Coronary Syndrome. Heart Views (2012) 0.95
Myocardial infarction causes inflammation and leukocyte recruitment at remote sites in the myocardium and in the renal glomerulus. Inflamm Res (2013) 0.94
High throughput mRNA profiling highlights associations between myocardial infarction and aberrant expression of inflammatory molecules in blood cells. Blood (2004) 0.94
Cytokine profiles and T cell function in acute coronary syndromes. Atherosclerosis (2006) 0.93
Monocyte chemoattractant protein-1/CCL2 as a biomarker in acute coronary syndromes. Curr Atheroscler Rep (2009) 0.92
Macrophage migration inhibitory factor for the early prediction of infarct size. J Am Heart Assoc (2013) 0.92
Elevation of plasma levels of macrophage migration inhibitory factor in patients with acute myocardial infarction. Am J Cardiol (2002) 0.89
Activation of peripheral blood mononuclear cells and extracellular matrix and inflammatory gene profile in acute myocardial infarction. Clin Sci (Lond) (2010) 0.89
Acute myocardial infarction leads to acceleration of atherosclerosis. Atherosclerosis (2013) 0.88
Increased interleukin-1β levels are associated with left ventricular hypertrophy and remodelling following acute ST segment elevation myocardial infarction treated by primary percutaneous coronary intervention. J Intern Med (2012) 0.87
Role of MIF in myocardial ischaemia and infarction: insight from recent clinical and experimental findings. Clin Sci (Lond) (2014) 0.87
Pro-inflammatory action of MIF in acute myocardial infarction via activation of peripheral blood mononuclear cells. PLoS One (2013) 0.86
Decreased fibrocyte number is associated with atherosclerotic plaque instability in man. Cardiovasc Res (2012) 0.84
The chemokine network in relation to infarct size and left ventricular remodeling following acute myocardial infarction. Am J Cardiol (2009) 0.81
Natural killer (NK) cell deficit in coronary artery disease: no aberrations in phenotype but sustained reduction of NK cells is associated with low-grade inflammation. Clin Exp Immunol (2014) 0.81
Aging adversely affects postinfarction inflammatory response and early left ventricular remodeling after reperfused acute anterior myocardial infarction. Cardiology (2005) 0.79
Multimarker risk strategy for predicting 1-month and 1-year major events in non-ST-elevation acute coronary syndromes. Am Heart J (2005) 0.79
Immunological changes in acute myocardial infarction. Saudi Med J (2004) 0.79
Circulating levels of soluble P-selectin in patients in the early and recent phases of myocardial infarction. Chang Gung Med J (2005) 0.78
T cell activation and enhanced apoptosis in non-ST elevation myocardial infarction. Clin Exp Med (2003) 0.78
Lower prevalence of circulating invariant natural killer T (iNKT) cells in patients with acute myocardial infarction undergoing primary coronary stenting. Int Immunopharmacol (2011) 0.77
Relation of admission white blood cell count to left ventricular remodeling after anterior wall acute myocardial infarction. Am J Cardiol (2007) 0.77
Cytokines in acute coronary syndromes. Int J Cardiol (2005) 0.76
The role of T-lymphocyte subpopulations in acute myocardial infarction. Eur J Intern Med (2003) 0.76
Interleukin-6 is the strongest predictor of 30-day mortality in patients with cardiogenic shock due to myocardial infarction. Crit Care (2012) 0.76
Significantly reduced function of T cells in patients with acute arterial thrombosis. J Geriatr Cardiol (2015) 0.87
Expression characteristics of neutrophil and mononuclear-phagocyte related genes mRNA in the stable angina pectoris and acute myocardial infarction stages of coronary artery disease. J Geriatr Cardiol (2015) 0.86